Literature DB >> 21703835

Relationships between serum total bilirubin levels and metabolic syndrome in Korean adults.

S H Choi1, K E Yun, H J Choi.   

Abstract

BACKGROUND AND AIMS: Metabolic syndrome (MS) is associated with insulin resistance in all parts of its natural history, which is accompanied by oxidative stress. Bilirubin is a potent endogenous antioxidant and cytoprotectant. The current study was performed to identify the major predictors of the total bilirubin level and to assess the relationships between the total bilirubin levels and MS in Korean adults. METHODS AND
RESULTS: This is a cross-sectional study involving 12342 adults aged 20 years and over who visited a Health Promotion Center. Physical examinations and laboratory tests including total and direct bilirubin levels were performed. MS was defined based on the modified NCEP-ATP III definition and the determinations of the Korean Society for the Study of Obesity. The results showed that hemoglobin had the strongest influence on the total bilirubin levels after adjusting for age, gender, and all other variables. The high-bilirubin group (≥15.4 μmol/L in males and ≥12.1 μmol/L in females) was associated with significantly decreased odds of MS compared to the low-bilirubin group (OR 0.74 [95% CI 0.64-0.86]). High levels of bilirubin also were negatively associated with abdominal obesity and hypertriglyceridemia. The total bilirubin levels decreased with an increase in the number of MS components after adjustment for all covariates.
CONCLUSION: Within the physiological range, the serum total bilirubin level was negatively associated with the MS in subjects without overt metabolic or cardiovascular diseases. This may be partially due to the negative association between the total bilirubin level and abdominal obesity and hypertriglyceridemia.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21703835     DOI: 10.1016/j.numecd.2011.03.001

Source DB:  PubMed          Journal:  Nutr Metab Cardiovasc Dis        ISSN: 0939-4753            Impact factor:   4.222


  38 in total

Review 1.  Biliverdin reductase isozymes in metabolism.

Authors:  Luke O'Brien; Peter A Hosick; Kezia John; David E Stec; Terry D Hinds
Journal:  Trends Endocrinol Metab       Date:  2015-02-25       Impact factor: 12.015

Review 2.  Haeme oxygenase signalling pathway: implications for cardiovascular disease.

Authors:  Laura E Fredenburgh; Allison A Merz; Susan Cheng
Journal:  Eur Heart J       Date:  2015-03-31       Impact factor: 29.983

3.  Mice with hyperbilirubinemia due to Gilbert's syndrome polymorphism are resistant to hepatic steatosis by decreased serine 73 phosphorylation of PPARα.

Authors:  Terry D Hinds; Peter A Hosick; Shujuan Chen; Robert H Tukey; Michael W Hankins; Andrea Nestor-Kalinoski; David E Stec
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-01-17       Impact factor: 4.310

4.  Bilirubin remodels murine white adipose tissue by reshaping mitochondrial activity and the coregulator profile of peroxisome proliferator-activated receptor α.

Authors:  Darren M Gordon; Kari L Neifer; Abdul-Rizaq Ali Hamoud; Charles F Hawk; Andrea L Nestor-Kalinoski; Scott A Miruzzi; Michael P Morran; Samuel O Adeosun; Jeffrey G Sarver; Paul W Erhardt; Robert E McCullumsmith; David E Stec; Terry D Hinds
Journal:  J Biol Chem       Date:  2020-05-13       Impact factor: 5.157

5.  Does bilirubin prevent hepatic steatosis through activation of the PPARα nuclear receptor?

Authors:  Terry D Hinds; Samuel O Adeosun; Abdulhadi A Alamodi; David E Stec
Journal:  Med Hypotheses       Date:  2016-08-31       Impact factor: 1.538

Review 6.  Bilirubin, a Cardiometabolic Signaling Molecule.

Authors:  Terry D Hinds; David E Stec
Journal:  Hypertension       Date:  2018-10       Impact factor: 10.190

7.  Relationship Between the Serum Total Bilirubin and Inflammation in Patients With Psoriasis Vulgaris.

Authors:  Zhen-Xing Zhou; Jian-Kui Chen; Yan-Ying Hong; Ru Zhou; Dong-Mei Zhou; Li-Yun Sun; Wen-Li Qin; Tian-Cheng Wang
Journal:  J Clin Lab Anal       Date:  2016-04-07       Impact factor: 2.352

Review 8.  Bilirubin as a metabolic hormone: the physiological relevance of low levels.

Authors:  Justin F Creeden; Darren M Gordon; David E Stec; Terry D Hinds
Journal:  Am J Physiol Endocrinol Metab       Date:  2020-12-07       Impact factor: 4.310

9.  The role of bilirubin in diabetes, metabolic syndrome, and cardiovascular diseases.

Authors:  Libor Vítek
Journal:  Front Pharmacol       Date:  2012-04-03       Impact factor: 5.810

10.  Effect of 2 years of calorie restriction on liver biomarkers: results from the CALERIE phase 2 randomized controlled trial.

Authors:  James L Dorling; Eric Ravussin; Leanne M Redman; Manju Bhapkar; Kim M Huffman; Susan B Racette; Sai K Das; John W Apolzan; William E Kraus; Christoph Höchsmann; Corby K Martin
Journal:  Eur J Nutr       Date:  2020-08-14       Impact factor: 5.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.